Friday, July 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ras”

843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 843
Index total 30,257
Page 27 / 36

Quick answer

This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

843 results for “ras” · 30,257 patents in full index Clear search

  1. US 7754461

    Large-scale production of human serum butyrylcholinesterase as a bioscavenger

    The United States of America as represented by the Secretary of the Army · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted

  2. US 7750121

    Antibody to telomerase reverse transcriptive

    The Regents of the University of Colorado · Granted Jul 6, 2010 · Expires Jul 1, 2030

    granted

  3. US 7750051

    Crystalline solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 6, 2010 · Expires Jul 1, 2030

    granted

  4. US 7745691

    Genetically modified mouse lacking diacylglycerol acyltransferase-1 (DGAT-1) activity

    The Regents of the University of California · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted

  5. US 7744851

    Methods and agents for preparing 18F-radiolabeled fluorinating agents

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted

  6. US 7740867

    Method for identification of virulence determinants

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 22, 2010 · Expires Jun 17, 2030

    granted

  7. US 7737177

    Processes for preparing crystalline and amorphous mupirocin calcium

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Jun 15, 2010 · Expires Jun 10, 2030

    granted

  8. US 7727992

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 1, 2010 · Expires May 27, 2030

    granted

  9. US 7727554

    Sustained-release nanoparticle compositions and methods for using the same

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Jun 1, 2010 · Expires May 27, 2030

    granted

  10. US 7727534

    Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted

  11. US 7709002

    Mutated ras peptides for generation of CD8+Cytotoxic T lymphocytes

    The United States of America, as represented by the Department of Health and Human Services · Granted May 4, 2010 · Expires Apr 29, 2030

    granted

  12. US 7705188

    Structural modification of resveratrol: sodium resverastatin phosphate

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Apr 27, 2010 · Expires Apr 22, 2030

    granted

  13. US 7696306

    Compositions and methods for preventing or treating cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted

  14. US 7696151

    Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Apr 13, 2010 · Expires Apr 8, 2030

    granted

  15. US 7683188

    Process for preparation of mycophenolic acid and ester derivatives thereof

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted

  16. US 7678799

    Crystalline ziprasidone HCl and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted

  17. US 7645876

    Processes for producing crystalline macrolides

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Jan 12, 2010 · Expires Jan 7, 2030

    granted

  18. US 7641909

    Avirulent, immunogenic flavivirus chimeras

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jan 5, 2010 · Expires Dec 31, 2029

    granted

  19. US 7622549

    Human telomerase reverse transcriptase polypeptides

    The Regents of the University of Colorado · Granted Nov 24, 2009 · Expires Nov 19, 2029

    granted

  20. US 7619117

    Rasagiline formulations and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 17, 2009 · Expires Nov 12, 2029

    granted

  21. US 7615573

    Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 10, 2009 · Expires Nov 5, 2029

    granted

  22. US 7608272

    Methods and compositions for vaccination of animals with PRRSV antigens with improved immunogenicity

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted

  23. US 7608714

    Production of dolasetron

    TEVA Gyógyszergyár Zártkörüen Müködö Részvénytárasaság · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted

  24. US 7608641

    Creatine oral supplementation using creatine hydrochloride salt

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.